PLK1 and cancer: According to the literature, PRC1 is regulated by PLK1-dependent phosphorylation, and inhibition of PLK1 or direct targeting of PRC1 can lead to its aberrant expression, subsequently causing cytokinesis defects and cancer progression [44].